Contact SRI Biosciences

Biosciences Press Releases- Archive

2010

Specific Changes in the Brain Associated with Sleep Deprivation Described in New Study by the Allen Institute for Brain Science and SRI
(11-03-10)

Distinguished Scientist H. Mario Geysen Join SRI to Lead Combinatorial Sciences and Metabolic Diseases Research Program
(10-27-10)

SRI International to Advance Clinical Development of TAS-108, a Late-Stage Breast Cancer Drug
(08-19-10)

SRI International Announces Recipients of Its 2010 Fellowship Award
(08-10-10)

SRI International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
(05-13-10)

SRI International Researchers Present Promising New Therapeutic for the Treatment of Multiple Myeloma
(05-11-10)

Walter Moos to Speak on Saving Lives through Innovation at the Baker Forum May 2 at Cal Poly
(04-22-10)

SRI International Awarded National Institutes of Health Preclinical Services Contract
(03-25-10)

SRI Researchers to Present Work on Early Detection Tool for Neglected Tropical Diseases at 2010 American Chemical Society (ACS) Meeting
(03-21-10)

SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program
(02-18-10)

SRI International Researcher Named American Association for the Advancement of Science (AAAS) Fellow
(01-21-10)

2009

SRI International and State and Regional Leaders Convene for Ribbon Cutting at New SRI Facility in St. Petersburg, Florida
(12-18-09)

SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System
(12-15-09)

SRI International and F. Hoffmann-La Roche Launch Translational Medicine Collaboration to Study Methods and Treatments Associated with Cognitive Deficits across Neuropsychiatric Disorders
(11-10-09)

SRI International and Regional and State Leaders Dedicate New SRI Shenandoah Valley Facility in Harrisonburg, Virginia
(11-09-09)

SRI International Awarded a Department of Defense "Laboratory-Clinical Transition" Grant to Advance SRI’s Novel Anticancer Agents for Prostate Cancer Treatment
(10-13-09)

SRI Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental Disorders
(10-05-09)

SRI International Executives Discuss Drug Discovery & Development at BioJapan 2009
(10-02-09)

FDA Approves Pralatrexate for Treatment of Peripheral T-Cell Lymphoma; Drug Discovered and Developed by SRI International, Memorial Sloan-Kettering Cancer Center, and Southern Research Institute
(09-25-09)

SRI International’s Research on Nicotine Use and Dependence Featured in the National Cancer Institute’s Tobacco Control Monograph Series
(09-10-09)

SRI International Announces Selection by the National Cancer Institute as a Chemical Biology Consortium Center
(07-22-09)

SmartPlanet interview with Jon Mirsalis, SRI Biosciences managing director

SRI International Research on Sleep and Wakefulness Featured in "Neurobiology Select" Series of the Journal Cell
(05-07-09)

SRI International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research by Krishna Kodukula and Amit Galande
(05-06-09)

SRI International Appoints Caroline Tolman-Salinas as Director of QCL Labs
(04-23-09)

SRI International's Nathan Collins to Lead BayBio 2009 Conference Panel on Outsourcing Preclinical R&D
(04-13-09)

SRI International Appoints Jim Rurka as Executive Director of Biosciences Commercialization
(02-04-09)

SRI International Partners with AuricX Pharmaceuticals on Oral Formulations of Vancomycin Antibiotic
(01-12-09)

Back to current press releases

2008

SRI Awarded National Institute on Drug Abuse Contract for Chemical Analysis of Opioid Peptides and Drugs of Abuse
(11-18-08)

SRI International to Present Strategies to Defeat Antibiotic Resistance at BioJapan 2008
(10-08-08)

SRI International Awarded Defense Threat Reduction Agency (DTRA) Contract to Discover and Develop Broad-Spectrum Antibiotics

(09-22-08)

SRI International Begins NIAID-Funded Drug Evaluation Program for Tuberculosis
(09-15-08)

SRI International to Present Case Studies on Outsourcing R&D at Annual BioLOGIC Europe Meeting
(09-10-08)

SRI International Research Team Identifies Rare Sleep-Activated Neurons in the Cerebral Cortex
(07-21-08)

SRI International Research Sheds Light on Fight-or-Flight Response  
(07-16-08) 

SRI International to Present SERM Case Study at the American Association for Cancer Research Annual Meeting
(04-09-08)

SRI International to Highlight Pathway Tools Capabilities at the Molecular Medicine Tri-Conference in San Francisco, March 25-28
(03-25-08)

Lidia Sambucetti Joins SRI International to Lead Cancer Drug Discovery Programs
(01-31-08)

SRI International, Shenandoah Valley Partnership and Other Partners Unveil Regional Workforce Initiative and Comprehensive Report
(01-25-08)

Back to current press releases

2007

SRI International and Public Officials Hold Groundbreaking Ceremony for New R&D Facility in Rockingham County, Virginia, on December 4
(12-04-07)

SRI International Awarded National Institute of Allergy and Infectious Diseases Contract to Develop Drugs and Therapeutics for HIV and AIDS-Associated Infections
(11-14-07)

Steven Samuelsson Joins SRI International's Biosciences Division as Director of Imaging
(11-02-07)

SRI International Awarded National Cancer Institute Contract to Evaluate Potential Cancer Drugs
(10-25-07)

SRI International Executive Walter Moos to Address Current Issues in Pharmaceutical Development
(10-19-07)

SRI International Awarded DTRA Contract to Identify Drugs Effective Against Biological Weapons
(10-04-07)

SRI International to Host 15th Annual Biotech Investing Conference
(09-27-07)

SRI International Executives Lead Seminar on Collaborative Drug Discovery and Development
(09-12-07)

SRI International and Pentax Corporation Develop Biomarkers for Oncology Diagnostics
(09-12-07)

SRI International Awarded National Institute of Allergy and Infectious Disease Contract to Develop AIDS Drug Formulations
(08-16-07)

SRI International Awarded DARPA Subcontract to Accelerate Vaccine Manufacturing Process

(07-17-07)

SRI International Cancer Drug SR 16388 Selected by the National Cancer Institute as Promising Treatment for Advanced Prostate Cancer

(06-20-07)

Promising Cancer Therapeutics Developed by SRI International

(06-01-07)

SRI International Reacquires Rights to Tirapazamine, a Phase III Cancer Drug (05-07-07)

SRI International  and Blanca Pharmaceuticals Collaborate to Develop Antibiotics for Drug-Resistant Infections

(03-28-07)

SRI International Awarded Department of Defense Contract to Develop Drug to Protect Soldiers from Chemical Warfare Agents

(03-20-07)

SRI International Announces New Manager of Operations for Quality Clinical Labs (QCL)

(02-13-07)

SRI International and Telik Announce Exclusive License for SRI to Develop Autoimmune and Inflammatory Disease Drug Candidate

(02-08-07)

Back to current press releases

Contact SRI Biosciences

       Last Updated Nov 8, 2010